CALR and cancer: A recent study also reported that cancer cells may avoid the exposure of CRT through a mechanism involving stanniocalcin-1 mediated retention of CRT in the cytoplasm (thus suggesting a pool of cytosolic CRT), a process that impairs phagocytosis by antigen-presenting cells and subsequent anticancer adaptive immunity [67].